| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |